SCHEMBL5453260

SCHEMBL5453260

Cc1cccc2nc(C(S)c3ncnc4[nH]cnc34)n(-c3ccccc3NCCCN(C)C)c(=O)c12

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 14/20 0.41
PIK3R1 P27986 6/20 0.41
PIK3CG P48736 7/20 0.38
PIK3CB P42338 4/20 0.38
PIK3CA P42336 4/20 0.38
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
HDAC5 Q9UQL6 1/20 0.38
TOP2A P11388 1/20 0.36
BRD4 O60885 1/20 0.35
ATAD2 Q6PL18 1/20 0.35
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL735636 0.86 PIK3CD (0.42) PIK3CDPIK3R1PIK3CGPIK3CBPIK3CA
SCHEMBL734119 0.83 PIK3CD (0.46) PIK3CDPIK3R1PIK3CGPIK3CBPIK3CA
SCHEMBL733237 0.83 PIK3CG (0.51) PIK3CDPIK3R1PIK3CGPIK3CBPIK3CA
SCHEMBL733233 0.83 PIK3CD (0.47) PIK3CDPIK3R1PIK3CGPIK3CBPIK3CA
SCHEMBL733544 0.81 PIK3CD (0.47) PIK3CDPIK3R1PIK3CGPIK3CBPIK3CA
SCHEMBL1425911 0.81 PIK3CG (0.56) PIK3CDPIK3R1PIK3CGPIK3CBPIK3CA
SCHEMBL734097 0.81 PIK3CG (0.51) PIK3CDPIK3R1PIK3CGPIK3CBPIK3CA
SCHEMBL27743792 0.80 PIK3CD (0.46) PIK3CDPIK3R1PIK3CGPIK3CBPIK3CA
SCHEMBL733812 0.79 PIK3CD (0.44) PIK3CDPIK3R1PIK3CGPIK3CBPIK3CA
SCHEMBL733438 0.77 PIK3CD (0.46) PIK3CDPIK3R1PIK3CGPIK3CBPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070238718-A1 THIAZOLYL-DIHYDRO-INDAZOLE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-10-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070238718-A1 THIAZOLYL-DIHYDRO-INDAZOLE CYP3A43, CYP3A5, UGT1A3 PIK3CD 3955/4885PIK3R1 4186/4885PIK3CG 4371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.